Europe — EMA

Palexia (Tapentadol)

Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a unknown/unknown for oral use. It is indicated for the management of moderate to severe acute pain in adults.

Tapentadol

International sale not permitted. Listed for the domestic market and B2B only.

Request sourcing

Pack/s

What is Tapentadol?

Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a unknown/unknown for oral use. It is indicated for the management of moderate to severe acute pain in adults.

GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Tapentadol used for?

Tapentadol acts as a centrally c … .... .... .... .... ... .... ... .... ... .... ...

What are the side effects of Tapentadol?

Common ...

What precautions apply to Tapentadol?

...

What does Tapentadol interact with?

....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →